Výsledky vyhledávání

Cytogenetic Risk Groups and Minimal Residual Disease Are Strong Prognostic Factors for Post-Transplant Outcome in Patients with Acute Myeloid Leukaemia and Myelodysplastic Syndrome

Autor: Olga Blau, Eckhard Thiel, Katja Graul, Annette Sindram, Igor Wolfgang Blau

Publikováno v: Blood. 118:4482-4482

Abstract 4482 Allogeneic stem cell transplantation (alloSCT) is a curative treatment option for patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). Relapse after alloSCT is still a major cause for the treatment failure. Mole

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c6722814237ab923c748a66a271e7cc0
https://doi.org/10.1182/blood.v118.21.4482.4482

Zobrazit plný text záznamu

Akademický článek

German Congress of Laboratory Medicine: 17th Annual Congress of the DGKL and 4th Symposium of the Biomedical Analytics of the DVTA e.V.

Publikováno v: Journal of Laboratory Medicine; Oct2022, Vol. 46 Issue 5, p1-87, 87p

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání